Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Clinical experience with piperacetazine in hospitalized mental patients. A four year study.

Ralston JD, Abreu BE.

J Indiana State Med Assoc. 1970 Nov;63(11):1291-6. No abstract available.

PMID:
5495472
2.

Nasal decongestant properties of some tetrahydrothiophene-1,1-dioxide derivatives.

Weaver LC, Alexander WM, Abreu BE.

Arch Int Pharmacodyn Ther. 1965 Aug;156(2):414-7. No abstract available.

PMID:
4161834
3.

Transplacental effects of drugs in mice.

Sinclair JG, Abreu BE.

Tex Rep Biol Med. 1965 Winter;23(4):849-53. No abstract available.

PMID:
5886414
4.

EFFECT OF ANTIEMETICS AND OTHER COMPOUNDS ON PROTOVERATRINE INDUCED EMESIS IN DOGS.

WEAVER LC, RAHDERT E, RICHARDS AB, ABREU BE.

J Pharm Sci. 1964 Apr;53:417-20. No abstract available.

PMID:
14189937
5.

Skeletal muscle studies by means of combined electromyography and needle biopsy. II. The muscle spindle.

BONSETT CA, ABREU BE.

Neurology. 1963 Apr;13:327-30. No abstract available.

PMID:
13968884
6.

Anticonvulsant and antitremor effects of chlorphenoxamine.

KERLEY TL, RICHARDS AB, BEGLEY RW, ABREU BE, WEAVER LC.

J Pharmacol Exp Ther. 1961 Jun;132:360-5. No abstract available.

PMID:
13752621
7.

Anticonvulsant activity of compounds related to methylparafynol.

WEAVER LC, ALEXANDER WM, ABREU BE.

Arch Int Pharmacodyn Ther. 1961 Apr 1;131:116-22. No abstract available.

PMID:
13783544
8.

Central nervous system effects of a local anesthetic, dyclonine.

WEAVER LC, RICHARDS AB, ABREU BE.

Toxicol Appl Pharmacol. 1960 Nov;2:616-27. No abstract available.

PMID:
13783547
9.

Specific blockade of the adrenal medulla.

GARDIER RW, ABREU BE, RICHARDS AB, HERRLICH HC.

J Pharmacol Exp Ther. 1960 Nov;130:340-5. No abstract available.

PMID:
13703587
10.

A study of certain analgetic-antipyreticcompounds.

WEAVER LC, ABREU BE.

J Am Pharm Assoc Am Pharm Assoc. 1960 May;49:298-301. No abstract available.

PMID:
13855321
11.

Pharmacology of some monohalogenated derivatives of sulfolane (tetrahydrothiophene-1,1-dioxide).

ALEXANDER WM, ABREU BE, WEAVER LC, FAITH HE, NEWBERNE JW.

Arch Int Pharmacodyn Ther. 1959 Apr 1;119(3-4):423-34. No abstract available.

PMID:
13650733
12.

Morphine antagonism with amiphenazole (2, 4-diamino-5-phenyl-thiazole hydrochloride).

WEAVER LC, JONES WR, RICHARDS AB, ABREU BE.

Proc Soc Exp Biol Med. 1959 Feb;100(2):304-5. No abstract available.

PMID:
13634120
13.

A study of the anesthetic properties of combinations of hexobarbital sodium and thialbarbitone sodium in dogs.

WEAVER LC, BURCH GR, ABREU BE, RICHARDS AB.

Am J Vet Res. 1958 Oct;19(73):940-2. No abstract available.

PMID:
13583386
14.

Polybenzarsol; a new amebicide.

JONES WR, NEWBERNE JW, FORNEY RB, BEGLEY RW, ALEXANDER WM, ABREU BE, WEAVER LC.

Antibiot Chemother (Northfield). 1958 Aug;8(8):400-5. No abstract available.

PMID:
24544890
15.

The mechanism of the hypotensive action of narcotine hydrochloride.

WEAVER LC, ALEXANDER WM, ABREU BE, RICHARDS AB, JONES WR, BEGLEY RW.

J Pharmacol Exp Ther. 1958 Aug;123(4):287-95. No abstract available.

PMID:
13564408
16.

The evaluation of two halogenated sulfolanes and pentylenetetrazol as antagonists to pentobarbital.

WEAVER LC, ALEXANDER WM, ABREU BE, BURCH GR.

J Pharmacol Exp Ther. 1956 Mar;116(3):268-72. No abstract available.

PMID:
13307388
17.

Pharmacologic properties of 4-alkoxy-beta-(1-piperidyl) propiophenones.

ABREU BE, RICHARDS AB, WEAVER LC, BURCH GR, BUNDE CA, BOCKSTAHLER ER, WRIGHT DL.

J Pharmacol Exp Ther. 1955 Dec;115(4):419-26. No abstract available.

PMID:
13272195
18.

Trichuricidal activity of phthalofyne and certain related compounds.

EHRENFORD FA, RICHARDS AB, ABREU BE, BOCKSTAHLER ER, WEAVER LC, BUNDE CA.

J Pharmacol Exp Ther. 1955 Aug;114(4):381-4. No abstract available.

PMID:
13252554
19.

Cardiovascular, emetic and pharmacodynamic properties of certain Veratrum alkaloids.

ABREU BE, RICHARDS AB, ALEXANDER WM, WEAVER LC.

J Pharmacol Exp Ther. 1954 Sep;112(1):73-9. No abstract available.

PMID:
13192611
20.

A comparison of the central and peripheral effects of atropine, scopolamine and some synthetic atropine-like compounds.

MEYERS FH, ABREU BE.

J Pharmacol Exp Ther. 1952 Apr;104(4):387-95. No abstract available.

PMID:
14918058
21.

Some effects of meperidine on gastro-enteric, extrahepatic biliary, and cardiovascular activity.

PICKERING RW, ABREU BE, et al.

J Am Pharm Assoc Am Pharm Assoc. 1949 Apr;38(4):188-92. No abstract available.

PMID:
18119730
22.

Influence of amphetamine sulfate on cerebral metabolism and blood flow in man.

ABREU BE, LIDDLE GW, et al.

J Am Pharm Assoc Am Pharm Assoc. 1949 Apr;38(4):186-8. No abstract available.

PMID:
18119729
23.

The pharmacology of beta-piperidinoethyl phenyl-alpha-thienylglycolate HCI.

PICKERING RW, ABREU BE, et al.

J Pharmacol Exp Ther. 1949 Feb;95(2):122-30. No abstract available.

PMID:
18111486
24.

Effects of amphetamine, dihydroergotamine, and methadon on human cerebral blood flow and oxygen uptake.

ABREU BE, LIDDLE GW, et al.

Fed Proc. 1948 Mar;7(1 Pt 1):201. No abstract available.

PMID:
18857919
25.
26.

Preliminary observations on the influence of ergotamine and dihydroergotamine on cerebral blood flow in the dog.

ABREU BE, LIDDLE GW, et al.

Fed Proc. 1947;6(1):304. No abstract available.

PMID:
20343633
27.

Undergraduate and graduate research in pharmacology in colleges of pharmacy.

ABREU BE.

Am J Pharm Educ. 1947 Jan;11(1):92-7. No abstract available.

PMID:
20288749
28.

Certain pharmacologic effects of beta-piperidinoethylphenyl-alpha-thienylglycolate.

CHEN JY, ABREU BE.

Fed Proc. 1947;6(1):316. No abstract available.

PMID:
20249561
29.
30.

Pharmacologic properties of p-carbamidophenylarsenous oxide.

ANDERSON HH, BOND VP, ABREU BE.

Fed Proc. 1946;5(1 Pt 2):162. No abstract available.

PMID:
21064276
31.

Central nervous system effects of anticholinergic agents.

ABREU BE, TUFTS RJ, COUTOLENC ME.

Fed Proc. 1946;5(1 Pt 2):161. No abstract available.

PMID:
20981919

Supplemental Content

Loading ...
Support Center